EX-99.1 2 pressrelease.htm PRESS RELEASE pressrelease.htm
 
Zarlink Delivers Strong Fiscal 2010 and Fourth Quarter Results

·  
Accelerating customer demand for network timing and line circuit products drives year-on-year increases in net income, gross margin and cash
·  
Quarter-on-quarter revenue increases by $4.1 million or 8% in Q4 Fiscal 2010, Company anticipates continuing growth in Q1, Fiscal 2011

OTTAWA, CANADA, May 27, 2010 – Zarlink Semiconductor (TSX: ZL) today issued Fiscal 2010 year end and fourth quarter results for the 12- and three-month periods ended March 26, 2010.  All figures are is U.S. dollars unless otherwise noted.

Fiscal 2010 Financial Highlights
·  
Operating efficiencies and expense reductions drove GAAP net income of $7.7 million, or $0.05 per basic share, compared with a GAAP net loss of $29.5 million or $0.25 per share in Fiscal 2009;
·  
Growing customer adoption of new higher margin products combined with supply chain efficiencies drove gross margin improvements, which increased to 51% of revenue, up from 48% in Fiscal 2009;
·  
Cash increased by $29.4 million to $74.4 million, as at March 26, 2010;
·  
The Company decreased operating expenses by more than $10 million, while maintaining R&D investments in core communications and medical programs.

Q4 Fiscal 2010 Financial Highlights
·  
Revenue grew to $58.5 million, up $4.1 million or 8% compared with revenue of $54.4 million in Q3 Fiscal 2010 and exceeded the Company’s guidance range of $56 million to $58 million;
·  
Revenue for the Company’s Communication Products group was $40.7 million in Q4 Fiscal 2010, up 20% from Q3 Fiscal 2010 and 48% from the same quarter last year;
·  
Gross margin increased to 53%, up from 52% in the previous quarter;
·  
GAAP earnings per share of $0.05 exceeded the Company’s guidance range of $0.02 to $0.04 per share excluding foreign exchange.

“Fiscal 2010 was a strong year for Zarlink in terms of financial and operational performance, with sales accelerating in the fourth quarter and now extending into Fiscal 2011,” said Kirk Mandy, President and CEO, Zarlink Semiconductor. “During the year we increased our gross margins, strengthened our bottom-line results and generated significant cash from operations, despite a challenging economic environment. Sales gained momentum as the year progressed, resulting in significant year-over-year and sequential growth in the fourth quarter, which we expect to continue in Fiscal 2011 with first quarter revenue growing sequentially by another 3% to 5%.”

Mr. Mandy continued: “Through customer design wins and the launch of new products throughout the year, we grew our presence in the key network timing and line circuit segments of the communication market, and solidified our position in the medical wireless market. In each of these areas, we believe there are immediate and emerging opportunities where we can leverage our expertise to grow the business. Our leading position in these market segments, combined with our improving balance sheet and cost structure, provide a technology roadmap and a solid financial footing to support our continued progress.”

Fiscal 2010 Financial Results
Fiscal 2010 revenue was $220.1 million, compared with $227.2 million in Fiscal 2009. Communication Products group revenue increased to $141.4 million from $140.0 million in Fiscal 2009 as a result of ramping demand for Zarlink’s network timing and line circuit products in the second half of the year.

Medical Products revenue was $30.0 million compared with $34.7 million in Fiscal 2009. The decline in revenue was due to uncertainty on the part of medical device manufacturers in the United States concerning healthcare reform, and an extended FDA qualification approval for a customer-specific platform lengthened certain product sales timelines.

Custom and Other revenue for Fiscal 2010 increased to $33.2 million, from $29.7 million in Fiscal 2009. Optical Products revenue for Fiscal 2010 was $15.5 million, compared with $22.7 million in Fiscal 2009. On May 17, 2010, Zarlink announced the sale of its Optical Products group to Tyco Electronics. Subsequent to the sale of the Optical Products Group, Zarlink expects to settle its Swedish pension liability in Q1, Fiscal 2011. This will utilize the restricted cash balance of $15.7 million, plus additional cash of $500,000.

Gross margin increased to 51% of revenue in Fiscal 2010, up from 48% of revenue in Fiscal 2009 and 45% of revenue in Fiscal 2008.

The Company continued to reduce expenses in Fiscal 2010, with improvements including:
·  
R&D expenses of $43.0 million, a decrease of $3.0 million or 7% compared with $46.0 million in Fiscal 2009;
·  
S&A expenses of $43.0 million, a decrease of $7.7 million or 15% compared with $50.6 million in Fiscal 2009.

Fiscal 2010 operating income was $19.1 million, with net income of $7.7 million or $0.05 per basic share and $0.04 per diluted share. Fiscal 2010 results include:
·  
A non-cash foreign exchange loss of $10.8 million related primarily to Zarlink’s Canadian dollar denominated debenture;
·  
Net interest expense of $3.7 million:
·  
Supply chain harmonization costs of $2.9 million related to transferring production with the Company’s foundry partners;
·  
Income tax recovery of $4.1 million;
·  
Impairment of asset held for sale of $1.2 million, which was partially offset by a $1.1 million recovery of current asset.

For Fiscal 2009, Zarlink recorded an operating loss of $44.4 million and a net loss of $29.5 million, or $0.25 per share, primarily due to a non-cash impairment charge of $46.9 million to write-off the book value of goodwill.

As a supplement to Zarlink's consolidated financial statements presented in accordance with U.S. Generally Accepted Accounting Principles (GAAP), the Company provides additional non-GAAP measures for operating income, net income (loss), and basis and diluted net earnings (loss) per share. For full reconciliation of GAAP to non-GAAP measures, refer to the schedule included with this press release.

Non-GAAP operating income for Fiscal 2010 was $31.0 million, compared with Fiscal 2009 non-GAAP operating income of $23.4 million. Non-GAAP net income in Fiscal 2010 was $26.8 million, or $0.20 per basic share and $0.18 per diluted share. For Fiscal 2009 non-GAAP net income was $20.7 million, or $0.15 per basic share and $0.14 per diluted share.

As at March 26, 2010, Zarlink had cash and short-term investments totaling $74.4 million, compared with $45.0 million at the end of Fiscal 2009.

Fourth Quarter Fiscal 2010 Financial Results
Fourth quarter revenue was $58.5 million, an increase of $4.1 million or 8% compared with Q3 Fiscal 2010 revenue of $54.4 million, and an increase of $7.4 million or 15% compared with Q4 Fiscal 2009 revenue of $51.1 million. Fourth quarter revenue exceeded the Company’s guidance of $56 million to $58 million.

Gross margin in Q4 Fiscal 2010 was 53% of revenue which included $0.3 million in supply chain harmonization costs, compared with 52% of revenue in the previous quarter which included $0.6 million in supply chain harmonization costs. Gross margin in Q4 Fiscal 2009 was 48% of revenue, which included severance costs of $0.8 million.

R&D expenses in Q4 Fiscal 2010 were $11.9 million, or 20% of revenue, compared with Q3 Fiscal 2010 R&D expenses of $10.9 million, or 20% of revenue. Increased R&D expenses in the quarter reflect material spend related to two significant product platform introductions. S&A expenses in Q4 Fiscal 2010 were $11.3 million, or 19% of revenue, compared with Q3 Fiscal 2010 S&A expenses of $11.2 million, or 21% of revenue.

Fourth quarter Fiscal 2010 operating income was $5.0 million, compared with Q3 Fiscal 2010 operating income of $4.5 million and Q4 Fiscal 2009 operating loss of $49.6 million. Net income in Q4 Fiscal 2010 was $6.8 million or $0.05 per share, which included a non-cash foreign exchange loss of $1.2 million related primarily to Zarlink’s Canadian dollar denominated debenture. Earnings per share exceed Q4 guidance of $0.02 to $0.04 per share, which excluded the impact of foreign exchange. In Q3 Fiscal 2010 Zarlink recorded net income of $0.6 million or break-even per share, which included a non-cash foreign exchange loss of $2.7 million. In Q4 Fiscal 2009 Zarlink recorded a net loss of $50.0 million, or $0.41 per share.

Non-GAAP operating income for Q4 Fiscal 2010 was $7.9 million, compared with Q3 Fiscal 2010 non-GAAP operating income of $7.3 million and Q4 Fiscal 2009 non-GAAP operating income of $3.8 million. Non-GAAP net income in Q4 Fiscal 2010 was $6.9 million, or $0.05 per share. For Q3 Fiscal 2010 non-GAAP net income was $6.1 million, or $0.05 per basic share and $0.04 per diluted share. For Q4 Fiscal 2009 non-GAAP net income was $1.3 million, or $0.01 per share.

On May 27, 2010 Zarlink declared a quarterly dividend of CDN$0.50 per share on its preferred shares (TSX:ZL.PR.A) payable on June 29, 2010 to preferred shareholders of record as of June 4, 2010. Dividends paid by Zarlink to Canadian residents are eligible dividends for Canadian income tax purposes.

Fourth Quarter Fiscal 2010 Business Summary
Fourth quarter revenue from Zarlink’s Communication Products Group was $40.7 million, up 20% compared with revenue of $33.8 million in Q3 Fiscal 2010 and 48% from revenue of $27.6 million in Q4 Fiscal 2009. The increase was due to very strong customer design activity for Zarlink’s line circuit and packet timing products.  In the quarter, Zarlink introduced a Timing over Packet reference design with Freescale Semiconductor that simplifies and speeds the development of new equipment for wireless service providers evolving to packet networks to support bandwidth-intense smartphone applications.

Q4 Fiscal 2010 revenue for the Company’s Medical Products Group was $5.3 million, compared with Q3 Fiscal 2010 revenue of $7.9 million and Q4 Fiscal 2009 revenue of $9.5 million.

Custom and Other revenue in Q4 Fiscal 2010 was $9.2 million, compared with $8.2 million in Q3 Fiscal 2010 and $9.8 million in Q4 Fiscal 2009. Optical Products revenue in Q4 Fiscal 2010 was $3.3 million, compared with revenue of $4.5 million in Q3 Fiscal 2010 and Q4 Fiscal 2009 revenue of $4.2 million.

First Quarter Fiscal 2011 Guidance
“Design activity with new and existing customers across key areas of our portfolio is approaching record levels,” said Mr. Mandy. “As a result, we expect sequential revenue growth of 3% to 5%, excluding revenue from our divested Optical Products group, based on continuing design wins for our packet network timing and new Clockcenter solutions, ramping demand for our line circuit products, and a strengthening end-market for our medical wireless technologies.

The opening backlog at the start of Q1 Fiscal 2011, adjusted to exclude optical products, was $58 million. Opening backlog at the start of Q4 Fiscal 2010, adjusted to exclude optical products, was $52 million. For Q1 Fiscal 2011 Zarlink is forecasting:
·  
Revenue between $57.0 million and $58.5 million;
·  
Gross margins between 50% and 51%, excluding supply chain harmonization costs of approximately $0.2 million;
·  
Operating expenses between $21 million and $22 million, excluding amortization of intangibles;
·  
A one-time charge of $2.0 million related to the settlement of the Swedish pension liability, which will utilize the restricted cash balance of $15.7 million plus additional cash of $500,000;
·  
Excluding any potential impact of foreign exchange, and including a $0.07 per share gain on sale of the Optical Products Group and a $0.02 per share loss on the settlement of the Swedish pension liability, Zarlink expects Q1 earnings of $0.07 to $0.09 per share.
 
 Analyst Conference Call
An open conference call for analysts will be held on May 27, 2010 beginning at 5:00 p.m. EDT. Access the call by dialing 1-877-974-0447. Investors, media and other parties are listen-only. For a replay, call 1-877-289-8525, Access Code 4301420# or 416-640-1917, Access Code 4301420#.The replay is available until midnight on June 10th, 2010. A live audio webcast will be available through http://www.marketwire.com/ (Marketwire) or from the Company's website at http://www.zarlink.com/.
 
About Zarlink Semiconductor
Zarlink Semiconductor delivers world-leading, mixed-signal chip technologies for a broad range of communication and medical applications. The company’s core capabilities include network timing solutions that manage time-sensitive communication applications over wireless and wired networks, line circuits supporting high-quality voice services over cable and broadband connections, and ultra low-power radios enabling new wireless medical devices and therapies. Serving the world’s largest original equipment manufacturers, Zarlink’s highly integrated chip solutions help customers simplify design, lower costs and reach market quickly. For more information, visit www.zarlink.com.

Shareholders and other individuals wishing to receive, free of charge, copies of the reports filed with the U.S. Securities and Exchange Commission and Canadian Securities Regulatory Authorities, should visit the Company’s web site at www.zarlink.com or contact Investor Relations.
 
Certain statements in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such risks, uncertainties and assumptions include, among others, the following: our dependence on the successful development and market introduction of new products; our ability to integrate any business, technologies, product lines or services that we have or will acquire; our dependence on revenue generation from our legacy products in order to fund development of our new products; current market conditions, including the lack of liquidity in the markets and economic slowdown, may increase our operating costs or reduce our revenue, thereby negatively impacting our operating results; our ability to operate profitably and generate positive cash flows in the future; the impact of the current economic crisis on our suppliers and customers and our ability to transfer parts to other suppliers; our dependence on our foundry suppliers and third-party subcontractors; order cancellations and deferrals by our customers; our substantial indebtedness could adversely affect our financial position; the cost and accounting implications of compliance with new accounting standards; and other factors referenced in our Annual Report on Form 20-F. Investors are encouraged to consider the risks detailed in this filing.
 

Zarlink and the Zarlink Semiconductor logo are trademarks of Zarlink Semiconductor Inc.
 

 
 
 

For further information:

Ed Goffin
Media Relations and Investor Relations
613 270-7112
edward.goffin@zarlink.com


 
 
 

 

Zarlink Semiconductor Inc.
CONSOLIDATED STATEMENTS OF INCOME (LOSS) DATA
(in thousands of U.S dollars, except per share amounts, U.S. GAAP)
(Unaudited)
 
   
Three Months Ended
   
Year Ended
 
   
Mar. 26,
   
Dec. 25,
   
Mar. 27,
   
Mar. 26,
   
Mar. 27,
 
   
2010
   
2009
   
2009
   
2010
   
2009
 
Revenue
  $ 58,512     $ 54,425     $ 51,101     $ 220,141     $ 227,165  
Cost of revenue
    27,544       26,074       26,745       107,028       118,131  
Gross margin
    30,968       28,351       24,356       113,113       109,034  
                                         
Expenses:
                                       
   Research and development
    11,909       10,930       12,434       42,976       45,994  
   Selling and administrative
    11,345       11,219       13,683       42,981       50,643  
   Amortization of intangible assets
    1,803       1,803       1,846       7,234       7,384  
   Contract impairment (recovery)
    -       (94 )     138       715       280  
   Impairment (recovery) of current asset
    (284 )     -       -       (1,052 )     3,000  
   Impairment of asset held for sale
    1,185       -       -       1,185       1,200  
   Goodwill impairment
    -       -       46,887       -       46,887  
   Gain on sale of business
    -       -       (1,000 )     -       (1,000 )
   Gain on sale of assets
    -       -       -       -       (936 )
      25,958       23,858       73,988       94,039       153,452  
Operating income (loss)
    5,010       4,493       (49,632 )     19,074       (44,418 )
                                         
Gain (loss) on repurchase of convertible debentures
    -       -       -       (316 )     3,593  
Amortization of debt issue costs
    (160 )     (161 )     (160 )     (641 )     (689 )
Interest income
    27       69       76       184       1,184  
Interest expense
    (1,006 )     (985 )     (852 )     (3,867 )     (4,145 )
Foreign exchange gain (loss)
    (1,245 )     (2,719 )     2,108       (10,843 )     14,028  
Net income (loss) before income taxes
    2,626       697       (48,460 )     3,591       (30,447 )
Income tax recovery (expense)
    4,193       (66 )     (1,516 )     4,063       903  
                                         
Net income (loss)
  $ 6,819     $ 631     $ (49,976 )   $ 7,654     $ (29,544 )
                                         
Net income (loss) attributable to common shareholders
  $ 6,268     $ 112     $ (50,304 )   $ 5,510     $ (31,717 )
                                         
Net income (loss) per common share:
                                       
    Basic
  $ 0.05     $ 0.00     $ (0.41 )   $ 0.05     $ (0.25 )
    Diluted
  $ 0.05     $ 0.00     $ (0.41 )   $ 0.04     $ (0.25 )
                                         
Weighted average number of common shares outstanding (thousands):
                                       
Basic
    121,518       122,293       122,426       122,163       124,798  
Diluted
    152,754       123,652       122,426       123,444       124,798  
                                         
Percentage of revenue:
                                       
Gross margin
    53 %     52 %     48 %     51 %     48 %
Research and development
    20 %     20 %     24 %     20 %     20 %
Selling and administrative
    19 %     21 %     27 %     20 %     22 %



 
1

 



Zarlink Semiconductor Inc.
CONSOLIDATED STATEMENTS OF CASH FLOWS DATA
(in thousands of U.S. dollars, U.S. GAAP)
(Unaudited)

   
Three Months Ended
   
Year Ended
 
   
Mar. 26,
   
Dec. 25,
   
Mar. 27,
   
Mar. 26,
   
Mar. 27,
 
   
2010
   
2009
   
2009
   
2010
   
2009
 
CASH PROVIDED BY (USED IN)
                             
Operating activities:
                             
Net income (loss)
  $ 6,819     $ 631     $ (49,976 )   $ 7,654     $ (29,544 )
Depreciation of fixed assets
    916       939       1,118       3,780       4,706  
Amortization of other assets
    1,963       1,964       2,006       7,875       8,073  
Stock compensation expense
    423       475       540       1,586       2,115  
Deferred income taxes
    (4,056 )     162       632       (3,811 )     2,813  
Other non-cash changes in operating activities
    2,651       2,802       (2,019 )     12,508       (12,808 )
Goodwill impairment
    -       -       46,887       -       46,887  
Decrease (increase) in working capital:
                                       
Trade accounts and other receivables
    3,054       (6,615 )     621       (2,482 )     3,712  
Inventories
    310       3,809       307       1,596       992  
Prepaid expenses and other
    (258 )     951       (364 )     376       3,380  
Payables and other accrued liabilities
    3,396       1,671       1,117       3,188       (15,153 )
Deferred revenue
    (53 )     1,770       (565 )     3,632       292  
Total
    15,165       8,559       304       35,902       15,465  
                                         
Investing activities:
                                       
Expenditures for fixed assets
    (281 )     (998 )     (524 )     (2,265 )     (3,594 )
Increase in restricted cash and cash equivalents
    (930 )     -       (517 )     (930 )     (517 )
Proceeds from sale of fixed assets
    15       -       -       15       984  
Matured short-term investments
    -       -       240       -       240  
Proceeds from sale of business
    -       -       1,000       -       1,000  
Total
    (1,196 )     (998 )     199       (3,180 )     (1,887 )
                                         
Financing activities:
                                       
Repurchase of convertible debentures
    -       -       -       (13 )     (2,594 )
Payment of dividends on preferred shares
    -       (474 )     (417 )     (1,417 )     (1,939 )
Repurchase of preferred shares
    (174 )     (144 )     (206 )     (1,023 )     (1,386 )
Repurchase of common shares
    (162 )     (642 )     -       (804 )     (2,707 )
Repurchase of treasury shares
    (1,289 )     -       -       (1,289 )     -  
Exercise of stock options
    75       -       -       75       -  
Total
    (1,550 )     (1,260 )     (623 )     (4,471 )     (8,626 )
                                         
Effect of currency translation on cash
    45       (102 )     (153 )     1,112       (2,307 )
                                         
Increase (decrease) in cash and cash equivalents
    12,464       6,199       (273 )     29,363       2,645  
                                         
Cash and cash equivalents, beginning of period
    61,905       55,706       45,279       45,006       42,361  
                                         
Cash and cash equivalents, end of period
  $ 74,369     $ 61,905     $ 45,006     $ 74,369     $ 45,006  


 
2

 

Zarlink Semiconductor Inc.
CONSOLIDATED BALANCE SHEETS DATA
(in thousands of U.S. dollars, U.S. GAAP)
(Unaudited)

   
Mar. 26,
   
Dec. 25,
   
Mar. 27,
 
   
2010
   
2009
   
2009
 
ASSETS
                 
                   
Current assets:
                 
Cash and cash equivalents
  $ 74,369     $ 61,905     $ 45,006  
Restricted cash and cash equivalents
    15,720       14,704       13,145  
Trade accounts receivable – net
    27,038       30,352       24,556  
Other accounts receivable – net
    4,248       3,987       4,300  
Inventories – net
    26,225       26,535       27,821  
Prepaid expenses and other
    2,305       2,048       2,681  
Current assets held for sale
    750       1,935       1,935  
Deferred income tax assets – current portion
    2,000       -       -  
      152,655       141,466       119,444  
                         
Fixed assets – net
    10,992       11,528       12,530  
Deferred income tax assets – net
    7,584       5,561       5,800  
Intangible assets – net
    41,871       43,674       49,106  
Other assets
    1,603       2,081       2,655  
    $ 214,705     $ 204,310     $ 189,535  
                         
LIABILITIES AND SHAREHOLDERS’ EQUITY
                       
                         
Current liabilities:
                       
Trade accounts payable
  $ 15,178     $ 11,885     $ 12,018  
Employee-related payables
    13,452       10,269       9,478  
Income and other taxes payable
    1,006       746       482  
Current portion of provisions for exit activities
    379       1,574       3,645  
Other accrued liabilities
    7,123       8,332       6,454  
Deferred revenue
    4,493       4,546       861  
Deferred income tax liabilities – current portion
    29       31       28  
      41,660       37,383       32,966  
                         
Long-term debt – convertible debentures
    68,900       67,567       57,203  
Long-term portion of provisions for exit activities
    246       323       200  
Pension liabilities
    16,636       16,208       14,690  
Deferred income tax liabilities – long-term portion
    -       31       28  
Long-term accrued income taxes
    2,208       2,192       2,408  
Other long-term liabilities
    569       545       830  
      130,219       124,249       108,325  
                         
Redeemable preferred shares, unlimited shares authorized; 1,001,600 shares issued and 999,000 outstanding as at March 26, 2010
    12,787       12,884       13,558  
                         
Shareholders’ equity:
                       
    Common shares, unlimited shares authorized; no par value; 121,606,782 shares issued and 120,906,782 outstanding as at March 26, 2010
    733,357       734,337       738,818  
Treasury shares, at cost, 700,000 shares
    (1,289 )     -       -  
Additional paid-in capital
    39,838       38,795       33,969  
Deficit
    (664,110 )     (670,454 )     (669,872 )
Accumulated other comprehensive loss
    (36,097 )     (35,501 )     (35,263 )
      71,699       67,177       67,652  
    $ 214,705     $ 204,310     $ 189,535  


 
3

 

Zarlink Semiconductor Inc.
SUPPLEMENTARY SCHEDULES
(in thousands of U.S. dollars, U.S. GAAP)
(Unaudited)
Geographic Information:

Revenue, based on the geographic location of Zarlink’s customers, was distributed as follows:

   
Three Months
         
Three Months
         
Three Months
       
   
Ended
   
% of
   
Ended
   
% of
   
Ended
   
% of
 
   
Mar. 26, 2010
   
Total
   
Dec. 25, 2009
   
Total
   
Mar. 27, 2009
   
Total
 
                                     
Asia – Pacific
  $ 31,563       54 %   $ 26,487       49 %   $ 24,434       48 %
Europe
    15,323       26       16,617       31       12,659       25  
Americas
    11,626       20       11,321       20       14,008       27  
    $ 58,512       100 %   $ 54,425       100 %   $ 51,101       100 %

   
Year
         
Year
       
   
Ended
   
% of
   
Ended
   
% of
 
   
Mar. 26, 2010
   
Total
   
Mar. 27, 2009
   
Total
 
                         
Asia – Pacific
  $ 115,622       53 %   $ 113,659       50 %
Europe
    59,625       27       59,276       26  
Americas
    44,894       20       54,230       24  
    $ 220,141       100 %   $ 227,165       100 %

Product Group Information:

Revenue, based on product group, was distributed as follows:

   
Three Months
         
Three Months
         
Three Months
       
   
Ended
   
% of
   
Ended
   
% of
   
Ended
   
% of
 
   
Mar. 26, 2010
   
Total
   
Dec. 25, 2009
   
Total
   
Mar. 27, 2009
   
Total
 
                                     
Communication Products
  $ 40,724       69 %   $ 33,818       62 %   $ 27,572       54 %
Medical Products
    5,266       9       7,937       15       9,488       19  
Optical Products
    3,279       6       4,463       8       4,209       8  
Custom & Other
    9,243       16       8,207       15       9,832       19  
    $ 58,512       100 %   $ 54,425       100 %   $ 51,101       100 %

   
Year
         
Year
       
   
Ended
   
% of
   
Ended
   
% of
 
   
Mar. 26, 2010
   
Total
   
Mar. 27, 2009
   
Total
 
                         
Communication Products
  $ 141,386       64 %   $ 140,036       62 %
Medical Products
    29,986       14       34,683       15  
Optical Products
    15,525       7       22,700       10  
Custom & Other
    33,244       15       29,746       13  
    $ 220,141       100 %   $ 227,165       100 %



 
4

 

Non-GAAP Measures

As a supplement to Zarlink’s consolidated financial statements presented in accordance with generally accepted accounting principles ("GAAP"), the Company provides additional non-GAAP measures for operating income, net income (loss), and basic and diluted net income (loss) per share.

A non-GAAP financial measure is a numerical measure of a company's performance, financial position, or cash flows that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.  The Company believes that the additional non-GAAP measures are useful to investors for the purpose of financial analysis.  Management uses these measures internally to evaluate the Company's in-period operating performance before gains, losses and other charges that are considered by management to be outside of the Company's core operating results.  These non-GAAP financial measures should assist investors in understanding how management views our core results of operations on an on-going basis, as well as enhance comparisons of our core results of operations with historical periods.  In addition, the measures are used for planning and forecasting of the Company's future periods.  Investors should consider non-GAAP financial measures in addition to, and not as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP.  The non-GAAP financial measures do not reflect all costs associated with our operations as determined in accordance with GAAP. Other companies may exclude or include different items in a particular non-GAAP financial measure, or provide different non-GAAP financial measures to those provided by Zarlink. Therefore, our non-GAAP financial measures are unlikely to be comparable to those presented by other companies.

Reconciliations of historical presentations of non-GAAP measures to their most directly comparable GAAP financial measures are provided in the following table.  The Company is unable to reconcile these non-GAAP measures on a forward-looking basis primarily because it is impractical to project certain events, such as the impact of foreign exchange gains/losses.

 
5

 
Zarlink Semiconductor Inc.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(in thousands of U.S. dollars, except per share amounts)
(Unaudited)

   
Three Months Ended
   
Year Ended
 
   
Mar. 26,
   
Dec. 25,
   
Mar. 27,
   
Mar. 26,
   
Mar. 27,
 
   
2010
   
2009
   
2009
   
2010
   
2009
 
                               
GAAP net income (loss)
  $ 6,819     $ 631     $ (49,976 )   $ 7,654     $ (29,544 )
Amortization of intangible assets
    1,803       1,803       1,846       7,234       7,384  
Goodwill impairment
    -       -       46,887       -       46,887  
Contract impairment (recovery)
    -       (94 )     138       715       280  
Foreign exchange loss (gain)
    1,245       2,719       (2,108 )     10,843       (14,028 )
Restructuring and supply chain harmonization
    (282 )     592       5,018       2,291       8,902  
Impairment of asset held for sale
    1,185       -       -       1,185       1,200  
Impairment (recovery) of current asset
    (284 )     -       -       (1,052 )     3,000  
Stock compensation expense
    423       475       540       1,586       2,115  
Gain on sale of business
    -       -       (1,000 )     -       (1,000 )
Gain on sale of assets
    -       -       -       -       (936 )
Loss (gain) on repurchase of convertible debentures
    -       -       -       316       (3,593 )
    Recovery related to deferred tax asset
    (4,000 )     -       -       (4,000 )     -  
Non-GAAP net income
  $ 6,909     $ 6,126     $ 1,345     $ 26,772     $ 20,667  
                                         
GAAP operating income (loss)
  $ 5,010     $ 4,493     $ (49,632 )   $ 19,074     $ (44,418 )
Amortization of intangible assets
    1,803       1,803       1,846       7,234       7,384  
Goodwill impairment
    -       -       46,887       -       46,887  
Contract impairment (recovery)
    -       (94 )     138       715       280  
Restructuring and supply chain harmonization
    (282 )     592       5,018       2,291       8,902  
Impairment of asset held for sale
    1,185       -       -       1,185       1,200  
Impairment (recovery) of current asset
    (284 )     -       -       (1,052 )     3,000  
Stock compensation expense
    423       475       540       1,586       2,115  
Gain on sale of business
    -       -       (1,000 )     -       (1,000 )
Gain on sale of assets
    -       -       -       -       (936 )
Non-GAAP operating income
  $ 7,855     $ 7,269     $ 3,797     $ 31,033     $ 23,414  
                                         
GAAP net income (loss) per common share - basic
  $ 0.05     $ 0.00     $ (0.41 )   $ 0.05     $ (0.25 )
Amortization of intangible assets
    0.01       0.01       0.02       0.06       0.06  
Goodwill impairment
    -       -       0.38       -       0.38  
Contract impairment (recovery)
    -       (0.00 )     0.00       0.01       0.00  
Foreign exchange loss (gain)
    0.01       0.02       (0.02 )     0.09       (0.11 )
Restructuring and supply chain harmonization
    (0.00 )     0.00       0.04       0.02       0.07  
Impairment of asset held for sale
    0.01       -       -       0.01       0.01  
Impairment (recovery) of current asset
    (0.00 )     -       -       (0.01 )     0.02  
Stock compensation expense
    0.00       0.00       0.00       0.01       0.02  
Gain on sale of business
          -        -       (0.01 )      -       (0.01 )
Gain on sale of assets
    -       -       -       -       (0.01 )
Loss (gain) on repurchase of convertible debentures
    -       -       -       0.00       (0.03 )
    Recovery related to deferred tax asset
    (0.03 )     -       -       (0.03 )     -  
Non-GAAP net income per common share – basic*
  $ 0.05     $ 0.05     $ 0.01     $ 0.20     $ 0.15  
                                         
GAAP net income (loss) per common share - diluted
  $ 0.05     $ 0.00     $ (0.41 )   $ 0.04     $ (0.25 )
Amortization of intangible assets
    0.01       0.01       0.02       0.05       0.05  
Goodwill impairment
    -       -       0.38       -       0.30  
Contract impairment (recovery)
    -       (0.00 )     0.00       0.00       0.00  
Foreign exchange loss (gain)
    0.01       0.02       (0.02 )     0.07       (0.09 )
Restructuring and supply chain harmonization
    (0.00 )     0.00       0.04       0.02       0.06  
Impairment of asset held for sale
    0.01       -       -       0.01       0.01  
Impairment (recovery) of current asset
    (0.00 )     -       -       (0.01 )     0.02  
Stock compensation expense
    0.00       0.00       0.00       0.01       0.01  
Gain on sale of business
    -       -       (0.01 )     -       (0.01 )
Gain on sale of assets
    -       -       -       -       (0.01 )
Loss (gain) on repurchase of convertible debentures
    -       -       -       0.00       (0.02 )
   Recovery related to deferred tax asset
    (0.03 )     -       -       (0.03 )     -  
   Effect of dilutive potential common shares
    -       0.00       -       0.01       0.07  
Non-GAAP net income per common share – diluted*
  $ 0.05     $ 0.04     $ 0.01     $ 0.18     $ 0.14  
                                         
Shares used to calculate non-GAAP net income per common share – basic
    121,518       122,293       122,426       122,163       124,798  
Shares used to calculate non-GAAP net income per common share – diluted
    152,754       152,576       122,426       152,371       153,731  
* Amounts may not add due to rounding.
 
6